CD200 and Miyoshi myopathy: For example, the BCMA/CD200/CD16A specific antibody is a tetravalent ‘aTriFlex’ TriAb characterized by a fusion protein bivalently engaged to CD16A on NK cells and two low-affinity binding single-chain antibodies targeting BCMA and CD200 on MM cells (81).